Neurology Clinical Trials Market to Reach USD 9.26 Billion by 2031, Driven by Rising CNS Research and Decentralized Study Models

Neurology Clinical Trials Market Overview and Growth Outlook 

The Neurology clinical trials market is witnessing steady expansion as global healthcare systems respond to the increasing burden of neurological disorders. According to Mordor Intelligence, the Neurology clinical trials market size is expected to grow from USD 6.25 billion in 2025 to USD 6.67 billion in 2026, reaching USD 9.26 billion by 2031, registering a CAGR of 6.78% during the forecast period. 

This growth is closely tied to rising cases of Alzheimer’s disease, Parkinson’s disease, stroke, and multiple sclerosis. As over one billion people are affected by neurological conditions globally, demand for effective therapies continues to rise. The Neurology clinical trials industry is also benefiting from improved regulatory pathways and increased funding for central nervous system (CNS) drug development. These factors are shaping Neurology clinical trials market trends and strengthening long-term Neurology clinical trials market growth. 

Key Trends Shaping the Neurology Clinical Trials Market 

• Increasing global prevalence of neurological disorders driving trial volumes 
• Rising investment in CNS drug pipelines, including gene and cell therapies 
• Adoption of decentralized and hybrid clinical trial models 
• Use of biomarkers and imaging tools for faster early-stage decision-making 
• Regulatory support for neurotherapeutics and digital interventions 

Stay ahead of the curve with global and localized reports-now available with detailed coverage of the Japanese market - https://www.mordorintelligence.com/ja/industry-reports/global-neurology-clinical-trials-market?utm_source=Industrytoday  

Market Segmentation 

• By Phase: Phase I, Phase II, Phase III, Phase IV 
• By Study Design: Interventional, Observational, Expanded Access 
• By Indication: Epilepsy, Stroke, Alzheimer’s Disease, Parkinson’s Disease, Multiple Sclerosis, Migraine, Amyotrophic Lateral Sclerosis, Other Indications 
• By Geography: North America, United States, Canada, Mexico, Europe, Germany, United Kingdom, France, Italy, Spain, Rest of Europe, Asia-Pacific, China, Japan, India, Australia, South Korea, Rest of Asia-Pacific, Middle East & Africa, GCC, South Africa, Rest of Middle East & Africa, South America, Brazil, Argentina, Rest of South America 

Key Players 

• Novartis AG  
• Biogen 
• F. Hoffmann-La Roche Ltd   
• Eli Lilly & Co. 
• Abbvie, Inc. 

Explore more insights on Neurology clinical trials competitive landscape: https://www.mordorintelligence.com/industry-reports/global-neurology-clinical-trials-market/companies?utm_source=Industrytoday  

Dominating Region: North America  

North America holds the largest Neurology clinical trials market share due to strong research infrastructure and regulatory support. The United States plays a central role, with the FDA offering accelerated pathways for neurodegenerative treatments and digital therapeutics. High investment levels from pharmaceutical companies and venture capital firms continue to support innovation in CNS therapies. The region also benefits from established contract research organizations (CROs) that provide advanced trial management capabilities. In addition, access to large patient populations and advanced healthcare systems enables efficient recruitment and execution of complex trials, reinforcing North America’s leadership in the Neurology clinical trials market forecast. 

Conclusion 

The Neurology clinical trials market  is steadily advancing as the need for effective treatments for neurological disorders continues to rise. Ongoing research efforts, supportive regulatory frameworks, and increasing industry investment are improving how trials are designed and conducted. The shift toward patient-friendly approaches and broader therapeutic exploration is shaping the future of the Neurology clinical trials industry. Despite operational and cost challenges, the overall outlook remains positive, with consistent progress expected as stakeholders focus on addressing unmet medical needs in neurology. 

Explore related reports from Mordor Intelligence 

Cell And Gene Therapy Market - https://www.mordorintelligence.com/industry-reports/cell-and-gene-therapy-market?utm_source=Industrytoday 

Clinical Trial Supply Market - https://www.mordorintelligence.com/industry-reports/clinical-trial-supply-market?utm_source=Industrytoday 

Clinical Trial Support Services Market - Source: https://www.mordorintelligence.com/industry-reports/clinical-trial-support-services-market?utm_source=Industrytoday  

About Mordor Intelligence: 

Mordor Intelligence is a trusted partner for businesses seeking actionable market insights. With 550+ domain experts and specialists across 150+ countries, we deliver comprehensive syndicated and custom research across industries such as aerospace, agriculture, chemicals, consumer goods, energy, healthcare, and many more, helping organizations make informed decisions and achieve strategic goals. 

For any inquiries or to access the full report, please contact: 

media@mordorintelligence.com 

https://www.mordorintelligence.com/